0
0
The Native Antigen Company Expands Infectious Disease Portfolio to Include Sudan Ebolavirus Boniface 1976 Glycoprotein - Business Wire
12/8/22 at 10:07am
Organization
Business Wire
41 words
0
Comments
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines an
You are the first to view
https://www.businesswire.com/news/home/20221208005427/en/The-Native-Antigen-Company-Expands-Infectious-Disease-Portfolio-to-Include-Sudan-Ebolavirus-Boniface-1976-Glycoprotein
Create an account or login to join the discussion